Login / Signup

Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid.

Melissa BirolSunil KumarElizabeth RhoadesAndrew D Miranker
Published in: Nature communications (2018)
Peptide mediated gain-of-toxic function is central to pathology in Alzheimer's, Parkinson's and diabetes. In each system, self-assembly into oligomers is observed and can also result in poration of artificial membranes. Structural requirements for poration and the relationship of structure to cytotoxicity is unaddressed. Here we focus on islet amyloid polypeptide (IAPP) mediated loss-of-insulin secreting cells in patients with diabetes. Newly developed methods enable structure-function enquiry to focus on intracellular oligomers composed of hundreds of IAPP. The key insights are that porating oligomers are internally dynamic, grow in discrete steps and are not canonical amyloid. Moreover, two classes of poration occur; an IAPP-specific ligand establishes that only one is cytotoxic. Toxic rescue occurs by stabilising non-toxic poration without displacing IAPP from mitochondria. These insights illuminate cytotoxic mechanism in diabetes and also provide a generalisable approach for enquiry applicable to other partially ordered protein assemblies.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • induced apoptosis
  • cell death
  • cognitive decline
  • cell cycle arrest
  • molecular dynamics
  • oxidative stress
  • cell proliferation
  • weight loss